Clinical Trial Update: Nipocalimab in Moderate to Severe Sjogren's Disease [Phase 3]

View source ↗

Summary

Phase 3 study of Nipocalimab for moderate to severe Sjögren's syndrome is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Nipocalimab (nipocalimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Sjogrens Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING